Announcements Trials
Browse Landscape

Phase

Phase 2 21Phase 3 9Phase 1 6Phase 2/3 2Phase 1/2 1

Status

Completed 6Active not recruiting 1

Sponsor Class

OTHER 4NETWORK 1INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 5Other solid neoplasm 1

Conditions

Stomach Neoplasms 2Gastrointestinal Neoplasms 1Carcinoma, Hepatocellular 1Biliary Tract Neoplasms 1Advanced Solid Tumors 1

Interventions

Paclitaxel 291Gemcitabine 254Carboplatin 253Cisplatin 250Radiotherapy 219Cyclophosphamide 218Irinotecan 184pembrolizumab 180Docetaxel 174Bevacizumab 166Capecitabine 148Nivolumab 141Fluorouracil 132Dexamethasone 125Bortezomib 123Oxaliplatin 115Cytarabine 113Erlotinib Hydrochloride 112Sorafenib 110Temozolomide 109Doxorubicin 106Rituximab 105Leucovorin 105Etoposide 105Filgrastim 99Everolimus 97Lenalidomide 95Ipilimumab 90Pemetrexed 89fludarabine phosphate 84

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 1 × Completed × titanium silicide × Clear all
NCT01693445 2016-02-19

S-1, Oxaliplatin, and Irinotecan for Advanced Gastrointestinal Cancer

Hallym University Medical Center

Phase 1 Completed
22 enrolled
Gastrointestinal

Gastrointestinal Neoplasms

NCT01128998 2015-10-19

Sorafenib Plus S-1 in Advanced Solid Tumors

National Health Research Institutes, Taiwan

Phase 1 Completed
30 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT01291615 2014-10-23

Phase I Study of Gemcitabine or S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer

Kansai Hepatobiliary Oncology Group

Phase 1 Completed
6 enrolled
Gastrointestinal

Biliary Tract Neoplasms

NCT01269255 2013-06-04

A Trial of Induction Chemotherapy and Chemoradiotherapy With TS-1 and Cisplatin (SP) as First-line Treatment in Patients With High Risk Advanced Gastric Cancer

Yonsei University

Phase 1 Completed
6 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01131689 2012-02-02

Trial of S-1 in Combination With Sorafenib for Patients With Advanced Hepatocellular Carcinoma

Samsung Medical Center

Phase 1 Completed
20 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT00960349 2011-06-14

Study of Cediranib Plus Cisplatin Plus Capecitabine/S-1 in Japanese Gastric Cancer Patients

AstraZeneca

Phase 1 Completed
14 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡